Follow
Markus Mitterhauser
Markus Mitterhauser
Professor for Radiopharmacy and Experimental Nuclear Medicine, Medical University of Vienna, Dept
Verified email at meduniwien.ac.at
Title
Cited by
Cited by
Year
Reduced serotonin-1A receptor binding in social anxiety disorder
RR Lanzenberger, M Mitterhauser, C Spindelegger, W Wadsak, N Klein, ...
Biological psychiatry 61 (9), 1081-1089, 2007
3802007
Basics and principles of radiopharmaceuticals for PET/CT
W Wadsak, M Mitterhauser
European journal of radiology 73 (3), 461-469, 2010
2122010
Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET
R Lanzenberger, P Baldinger, A Hahn, J Ungersboeck, M Mitterhauser, ...
Molecular psychiatry 18 (1), 93-100, 2013
1342013
11C-Acetate Positron Emission Tomography Imaging and Image Fusion With Computed Tomography and Magnetic Resonance Imaging in Patients With Recurrent …
S Wachter, S Tomek, A Kurtaran, N Wachter-Gerstner, B Djavan, ...
Journal of clinical oncology 24 (16), 2513-2519, 2006
1342006
Positron emission tomography imaging of adrenal masses: 18F-fluorodeoxyglucose and the 11β-hydroxylase tracer 11C-metomidate
G Zettinig, M Mitterhauser, W Wadsak, A Becherer, C Pirich, H Vierhapper, ...
European journal of nuclear medicine and molecular imaging 31, 1224-1230, 2004
1342004
Differential modulation of the default mode network via serotonin-1A receptors
A Hahn, W Wadsak, C Windischberger, P Baldinger, AS Höflich, J Losak, ...
Proceedings of the National Academy of Sciences 109 (7), 2619-2624, 2012
1322012
Normative database of the serotonergic system in healthy subjects using multi-tracer PET
M Savli, A Bauer, M Mitterhauser, YS Ding, A Hahn, T Kroll, A Neumeister, ...
Neuroimage 63 (1), 447-459, 2012
1282012
Influence of escitalopram treatment on 5-HT1A receptor binding in limbic regions in patients with anxiety disorders
C Spindelegger, R Lanzenberger, W Wadsak, LK Mien, P Stein, ...
Molecular psychiatry 14 (11), 1040-1050, 2009
1262009
Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas
R Lanzenberger, GS Kranz, D Haeusler, E Akimova, M Savli, A Hahn, ...
Neuroimage 63 (2), 874-881, 2012
1212012
PSMA Ligand PET/MRI for Primary Prostate Cancer: Staging Performance and Clinical ImpactPSMA-PET/MRI in Primary Prostate Cancer
B Grubmüller, P Baltzer, S Hartenbach, D D’Andrea, TH Helbich, ...
Clinical Cancer Research 24 (24), 6300-6307, 2018
1202018
Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats
T Reiberger, B Angermayr, P Schwabl, N Rohr-Udilova, M Mitterhauser, ...
Journal of hepatology 51 (5), 865-873, 2009
1182009
Aggression is related to frontal serotonin‐1A receptor distribution as revealed by PET in healthy subjects
AV Witte, A Flöel, P Stein, M Savli, LK Mien, W Wadsak, C Spindelegger, ...
Human brain mapping 30 (8), 2558-2570, 2009
1182009
Pgp‐Mediated Interaction Between (R)‐[11C]Verapamil and Tariquidar at the Human Blood–Brain Barrier: A Comparison With Rat Data
M Bauer, M Zeitlinger, R Karch, P Matzneller, J Stanek, W Jäger, ...
Clinical Pharmacology & Therapeutics 91 (2), 227-233, 2012
1172012
EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer
TD Poeppel, D Handkiewicz-Junak, M Andreeff, A Becherer, A Bockisch, ...
European journal of nuclear medicine and molecular imaging 45, 824-845, 2018
1052018
Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts
S Toegel, O Hoffmann, W Wadsak, D Ettlinger, LK Mien, K Wiesner, ...
European journal of nuclear medicine and molecular imaging 33, 491-494, 2006
992006
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
B Grubmüller, D Senn, G Kramer, P Baltzer, D D’Andrea, KH Grubmüller, ...
European journal of nuclear medicine and molecular imaging 46, 1063-1072, 2019
952019
High-dose testosterone treatment increases serotonin transporter binding in transgender people
GS Kranz, W Wadsak, U Kaufmann, M Savli, P Baldinger, G Gryglewski, ...
Biological psychiatry 78 (8), 525-533, 2015
892015
Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET
M Fink, W Wadsak, M Savli, P Stein, U Moser, A Hahn, LK Mien, K Kletter, ...
Neuroimage 45 (2), 598-605, 2009
892009
Glioma survival prediction with combined analysis of in vivo 11C-MET PET features, ex vivo features, and patient features by supervised machine learning
L Papp, N Pötsch, M Grahovac, V Schmidbauer, A Woehrer, M Preusser, ...
Journal of Nuclear Medicine 59 (6), 892-899, 2018
88*2018
[68Ga] Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques
X Li, D Heber, T Leike, D Beitzke, X Lu, X Zhang, Y Wei, M Mitterhauser, ...
European Journal of Nuclear Medicine and Molecular Imaging 45, 558-566, 2018
852018
The system can't perform the operation now. Try again later.
Articles 1–20